Milesy, sorry to burst your bubble but it looks like another company has beaten PIQ to the market and sales in the US for the kidney tests. This was taken from the Renalytix website and they have just sold 1k of billable tests in the US in the last quarter according to their latest press release from its CEO.
Maybe PIQ can get the Endo test to market quicker. I wonder how their TGA and FDA approvals are going for that test?
Ann: PromarkerD predictive test for DKD launched in Australia, page-19
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.015(4.17%) |
Mkt cap ! $61.32M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 36.0¢ | $12.40K | 33.81K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 104381 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 3883 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |